Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Surg Oncol. 2006 Nov;32(9):970-3. Epub 2006 Sep 22.

Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.

Author information

  • 1National Cancer Institute, Via M. Semmola, 80131 Naples, Italy. <>



To analyse the age as prognostic factor exploring the melanoma database at the National Cancer Institute in Naples.


Three hundred and ninety-nine patients with cutaneous melanoma were treated with sentinel lymph node biopsy from 1996 to 2003 at the National Cancer Institute of Naples. The results were analysed with particular attention to the overall survival among patients younger or older than 50 years of age.


No differences were recorded between the younger and older group in terms of the identification rate and incidence of metastases. The analyses of disease-free survival and overall survival showed a significantly more favourable outcome in younger patients. The 5-year overall survival and the 5-year disease free survival were 81.8% vs. 68.0% and 76.3% vs. 59.1% for the younger and older group, respectively.


The results suggest that in the management of cutaneous melanoma, age might be considered as prognostic factor both for disease free survival and overall survival.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk